Inspire Medical Systems (INSP) reported Q3 earnings late Monday of $0.60 per diluted share, swinging from a net loss of $0.29 a year earlier.
Analysts polled by Capital IQ expected $0.06.
Revenue for the quarter that ended Sept. 30 was $203.2 million, up from $153.3 million a year earlier.
Analysts surveyed by Capital IQ expected $197.6 million.
The company now expects full-year 2024 earnings of between $1.20 and $1.40 per diluted share, compared with its prior forecasts of $0.60 to $0.80. Analysts surveyed by Capital IQ expect $0.75.
The company now expects revenue for the full year of between $793 million and $798 million, versus its previous projections of $788 million to $798 million. Analysts polled by Capital IQ expect $795.1 million.
Shares of Inspire Medical Systems were up over 2% in after-hours activity.
Comments